XR-assisted CT-guided localization for EC-IC bypass in Moyamoya and chronic cerebral ischemia
Official title: Application of Extended Reality (XR)-Assisted CT-Guided Localization in Extracranial-intracranial (EC-IC) Bypass Surgery
Run by National Taiwan University Hospital · NCT07711457 · Data updated 2026-11-12
The study tests whether a metaverse-based surgical simulation with extended reality helps localize vessels during EC-IC bypass for moyamoya disease or chronic cerebral ischemia.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 1 site (Taipei) |
| Status | Recruiting |
| Started | June 26, 2026 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | July 23, 2026 |
| Trial ID | NCT07711457 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adult patients with ischemic moyamoya disease, moyamoya syndrome, or chronic ICA stenosis/occlusion who are scheduled for EC-IC bypass using STA/ECA donor vessels at NTU Hospital.
✕Probably not a fit
Patients with contraindications to CT, severe comorbidity, or those needing emergency surgery may not benefit from this technology or may be excluded from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study will use the NTU OpVerse platform to import preoperative CT images into a metaverse-based simulation for EC-IC bypass procedures. Extended reality will guide precise localization of donor and recipient vessels during surgery. The primary goal is to measure localization accuracy, with secondary aims to see if the technology enables a minimally invasive approach and enhances surgical safety. Participants are adults with moyamoya or chronic intracranial ICA disease scheduled for STA-based revascularization at National Taiwan University Hospital. The study will assess feasibility and potential benefits of XR-guided planning and intraoperative localization in real-world clinical settings.
Why it matters
Potential benefit: If successful, XR-assisted localization could improve precision, potentially reduce surgical risk, and support less invasive EC-IC bypass procedures.
How similar studies have gone: Prior studies have explored XR and simulation in surgical planning with promising but variable results; this study adds observational data on vessel localization accuracy in EC-IC bypass.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients diagnosed with ischemic moyamoya disease, moyamoya syndrome, or chronic intracranial internal carotid artery stenosis or occlusion (chronic ICA stenosis/occlusion). * Patients scheduled to undergo extracranial-intracranial bypass surgery (EC-IC bypass), including superficial temporal artery-middle cerebral artery bypass (STA-MCA bypass), superficial temporal artery trunk-interposition graft-middle cerebral artery bypass (STA trunk-graft-MCA bypass), or other cerebral revascularization procedures using the superficial temporal artery or another branch of the external carotid artery system (STA/ECA system) as the donor blood supply. Exclusion Criteria: * Presence of a contraindication to computed tomography (CT) scanning. * Presence of a severe systemic illness that would prevent participation in subsequent study assessments, such as poorly controlled diabetes mellitus, active malignancy, or severe cardiac disease. * The need for emergency surgery without sufficient time to complete image-based modeling and registration. * Presence of scalp lesions, wounds, or anatomical deformities that prevent reliable surface registration. * The XR registration result is considered unreliable by the research team and may potentially compromise surgical safety.
Where it's running
-
National Taiwan University Hospital
Taipei, Taiwan Recruiting
Study contacts
- Study coordinator: Chiu Hao Hsu
- Email: newmanhsu0814@gmail.com
- Phone: 88623123456
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Risk prediction for stroke and cognitive decline in Moyamoya disease and Moyamoya syndrome
A large multicenter study tests whether combining clinical data, imaging, lab and genetic information can predict who will have stroke or cognitive decline among people with Moyamoya.
-
5T MRI and Metabolomics to Predict Hemorrhage Risk in Moyamoya Disease
This study tests whether advanced 5T MRI imaging and metabolomics can help predict which moyamoya patients are at higher risk of intracranial hemorrhage.
-
Family screening and early detection for moyamoya disease
This project will try to find biological signs and 5T high-resolution MRI features that could detect moyamoya earlier in people with the disease, their first-degree relatives, and people without a family history.
-
Remimazolam: target-controlled infusion versus manual infusion during cerebrovascular bypass
This trial will test whether target-controlled infusion uses less remimazolam than manual infusion in adults undergoing cerebrovascular bypass surgery for moyamoya disease.
-
Cardiac index–guided blood flow management during pediatric Moyamoya EDAS surgery
This study will test whether using each child's cardiac index to guide fluids and hemodynamic care during EDAS lowers postoperative transient ischemic episodes in children with Moyamoya disease.
-
Combined cognitive and motor training for people with stroke or Moyamoya disease
This trial will test whether combined cognitive-motor training helps people with post-stroke cognitive impairment or Moyamoya disease improve their thinking and movement.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.